Abstract:Objective Protein arginine methyltransferases (PRMTs) play pivotal roles in numerous cellular biological processes.However, the precise regulatory effects of PRMTs on the fate determination of mesenchymal stromal/stem cells (MSCs) remain elusive. Our previous studies have shed light on the regulatory role and molecular mechanism of PRMT5 in MSC osteogenic differentiation. This study aims to clarify the role and corresponding regulatory mechanism of PRMT7 during the adipogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs).Methods(1) Human bone marrow-derived mesenchymal stem cells (hBMSCs) were cultured in a medium that induces adipogenesis. We used qRT-PCR and Western blot to monitor changes in PRMT7 expression during adipogenic differentiation.(2) We created a cell line with PRMT7 knocked down and assessed changes in PRMT7 expression and adipogenic capacity using Oil Red O staining, qRT-PCR and Western blot.(3) We implanted hBMSCs cell lines mixed with a collagen membrane subcutaneously into nude mice and performed Oil Red O staining to observe ectopic lipogenesis in vivo.(4) A cell line overexpressing PRMT7 was generated, and we examined changes in PRMT7expression using qRT-PCR and Western blot. We also performed Oil Red O staining and quantitative analysis after inducing the cells in lipogenic medium. Additionally, we assessed changes in PPAR gamma expression.(5) We investigated changes in insulin-like growth factor 1(IGF-1) expression in both PRMT7 knockdown and overexpressing cell lines using qRT-PCR and Western blot, to understand PRMT7's regulatory effect on IGF-1 expression. siIGF-1 was transfected into the PRMT7 knockdown cell line to inhibit IGF-1expression, and knockdown efficiency was confirmed. Then, we induced cells from the control and knockdown groups transfected with siIGF-1 in lipogenic medium and performed Oil Red O staining and quantitative analysis. Finally, we assessed PPAR gamma expression to explore IGF-1's involvement in PRMT7's regulation of adipogenic differentiation in hBMSCs.Results(1) During the adipogenesis process of hBMSCs, the expression level of PRMT7 was significantly reduced (P<0.01).(2) The adipogenic differentiation ability of PRMT7 knockdown group was significantly stronger than that of control group (P<0.001).(3) The ectopic adipogenic differentiation ability of PRMT7 knockdown group was significantly stronger than that of control group.(4) The adipogenic differentiation ability of the PRMT7 overexpression group was significantly weaker than that of the control group (P<0.01).(5) The expression level of IGF-1 increased after PRMT7 knockdown (P<0.0001). The expression level of IGF-1 decreased after PRMT7 overexpression (P<0.0001), indicating that PRMT7 regulates the expression of IGF-1. After siIGF-1 transfection, the expression level of IGF-1 in all cell lines decreased significantly (P<0.001). The ability of adipogenic differentiation of knockdown group transfected with siIGF-1 was significantly reduced (P<0.01), indicating that IGF-1 affects the regulation of PRMT7 on adipogenic differentiation of hBMSCs.Conclusion In this investigation, our findings elucidate the inhibitory role of PRMT7 in the adipogenic differentiation of hBMSCs, as demonstrated through both in vitro cell-level experiments and in vivo subcutaneous transplantation experiments conducted in nude mice. Mechanistic exploration revealed that PRMT7's regulatory effect on the adipogenic differentiation of hBMSCs operates via modulation of IGF-1 signaling pathway. These collective findings underscore PRMT7 as a potential therapeutic target for fatty metabolic disorders, thereby offering a novel avenue for leveraging PRMT7 and hBMSCs in the therapeutic landscape of relevant diseases.

Protein arginine methyltransferase PRMT1 promotes adipogenesis by modulating transcription factors C/EBP and PPAR

Protein arginine methyltransferase PRMT1 promotes adipogenesis by modulating transcription factors C/EBPβ and PPARγ

Protein Arginine Methyltransferase 1 Interacts With PGC1α and Modulates Thermogenic Fat Activation

Protein Arginine Methyltransferase 1 is Required for Maintenance of Normal Adult Hematopoiesis

Protein Arginine Methyltransferase PRMT5 Regulates Fatty Acid Metabolism and Lipid Droplet Biogenesis in White Adipose Tissues

Depletion of Prmt1 in Adipocytes Impairs Glucose Homeostasis in Diet-Induced Obesity

Hepatic PRMT1 ameliorates diet-induced hepatic steatosis via induction of PGC1α

PRMT4 facilitates white adipose tissue browning and thermogenesis by methylating PPARγ

PRMT7 Regulates Adipogenic Differentiation of Hbmscs by Modulating IGF-1 Signaling

Protein Arginine Methyltransferase 4 Regulates Adipose Tissue Lipolysis in Type 1 Diabetic Mice

Arginine Methyltransferase PRMT1 Regulates p53 Activity in Breast Cancer

Prmt6 represses the pro-adipogenic Ppar-gamma–C/ebp-alpha transcription factor loop

PRMT1 in human neoplasm: cancer biology and potential therapeutic target

Protein Arginine Methyltransferase 1 Promotes Epithelial-Mesenchymal Transition Via TGF-β1/Smad Pathway in Hepatic Carcinoma Cells

MiR-499/PRDM16 Axis Modulates the Adipogenic Differentiation of Mouse Skeletal Muscle Satellite Cells.

The Role of PRMT1 in Cellular Regulation and Disease: Insights into Biochemical Functions and Emerging Inhibitors for Cancer Therapy

CARM1/PRMT4 is necessary for the glycogen gene expression programme in skeletal muscle cells

AMPK/α-Ketoglutarate Axis Dynamically Mediates DNA Demethylation in the Prdm16 Promoter and Brown Adipogenesis.

MYPT1-PP1β phosphatase negatively regulates both chromatin landscape and co-activator recruitment for beige adipogenesis

PRMT1 Integrates Immune Microenvironment and Fatty Acid Metabolism Response in Progression of Hepatocellular Carcinoma

Overview of PRMT1 modulators: Inhibitors and degraders